After two decades in pharma, one thing stands out time and again: timing is everything—and so is decisive action. This holds especially true in the race to be first to file a generic. Even a minor delay in the NCE-1 timeline can derail critical milestones and compromise the return on R&D investment.
At Spring Bio Solution, with over 14 years of experience in clinical trial sourcing, we offer more than just data—we deliver an integrated system that empowers generic drug makers to accelerate filing with clarity and confidence.
Why We Developed NCE Grid
We developed NCE Grid not as a standalone tool, but as a strategic intelligence layer within our full services offering. It empowers generic pharma teams to identify and act on high-value Para IV opportunities precisely and proactively.
Because in the Para IV strategy, timing alone doesn’t win; execution does.
From Insight to Action
At Spring Bio Solution, we have packaged the NCE Grid with our comprehensive suite of services to ensure your team can move from early insight to regulatory submission without delays or disconnects. Our end-to-end support extends across the entire lifecycle of generic drug development:
- Comparator and RLD sourcing through a vetted global network
- Regulatory support to simplify and speed up ANDA filings
- Validated cold chain and trial logistics across key clinical markets
- Serialization and DSCSA compliance, powered by our partnership with LSPedia
- Referral for cost-effective litigation counsel
“Success in Para IV filings isn’t just about identifying NCE-1 opportunities; it’s about having the capabilities to act on them. Spring Bio Solution delivers intelligence through NCE Grid and end-to-end services to support generic drug development.”
— Salim Shaikh, Founder & CEO, Spring Bio Solution
Together, these services help teams move efficiently from early molecule evaluation to a complete, submission-ready dossier.
NCE Grid: Making Intelligence Actionable
NCE Grid is built specifically to uncover the NCE-1 filing windows, giving teams a real-time strategic view of emerging Para IV opportunities. By transforming fragmented regulatory data into structured, actionable insights, it helps your team:
- Track upcoming NCE-1 expiries across therapeutic areas
- Analyze molecule profiles, revenue potential, and market dynamics
- Stay ahead in identifying and claiming first-filer opportunities
In many companies, scattered spreadsheets and delayed coordination create avoidable bottlenecks. We’ve seen promising generic programs stumble, not due to science, but because they weren’t ready when it mattered most.
Execution-Ready Support for Para IV Strategy
That’s why NCE Grid is only the beginning. Our value lies in our ability to help clients transition seamlessly from opportunity identification to clinical and regulatory execution. Whether it’s sourcing hard-to-find comparators, navigating filing complexity, or ensuring compliant delivery across borders, we’re your partner in speed, precision, and readiness.
Redefining Competitive Readiness
In today’s generics market, the companies that succeed are the ones who spot opportunities early and are ready to act. With Spring Bio Solution, you’re not just spotting NCE-1 opportunities; you’re equipped to act on them.
With NCE Grid and our full-service support model, we help our clients turn insight into action with unmatched speed and confidence.
Because when you think Para IV, think NCE Grid—from Spring Bio Solution.
